0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Repurposing Serveice Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-1F15743
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Repurposing Serveice Market Research Report 2023
BUY CHAPTERS

Global Drug Repurposing Serveice Market Research Report 2025

Code: QYRE-Auto-1F15743
Report
January 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Drug Repurposing Serveice Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Drug Repurposing Serveice Market

Drug Repurposing Serveice Market

The global market for Drug Repurposing Serveice was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Repurposing Serveice, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repurposing Serveice.
The Drug Repurposing Serveice market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Repurposing Serveice market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repurposing Serveice companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Repurposing Serveice Market Report

Report Metric Details
Report Name Drug Repurposing Serveice Market
CAGR 5%
Segment by Type
  • Target-centric
  • Drug-centric
  • Disease-centric
Segment by Application
  • Cardiovascular Disorders
  • Central Nervous Disorders
  • Oncology
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Anaxomics Biotech SL, Biovista, Chemotargets, IQVIA, Eurofins DiscoverX, NUVISAN, CD ComputaBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Repurposing Serveice company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Repurposing Serveice Market report?

Ans: The main players in the Drug Repurposing Serveice Market are Anaxomics Biotech SL, Biovista, Chemotargets, IQVIA, Eurofins DiscoverX, NUVISAN, CD ComputaBio

What are the Application segmentation covered in the Drug Repurposing Serveice Market report?

Ans: The Applications covered in the Drug Repurposing Serveice Market report are Cardiovascular Disorders, Central Nervous Disorders, Oncology, Others

What are the Type segmentation covered in the Drug Repurposing Serveice Market report?

Ans: The Types covered in the Drug Repurposing Serveice Market report are Target-centric, Drug-centric, Disease-centric

Recommended Reports

Pharmaceutical Services

Drug Development

Disease Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Repurposing Serveice Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Target-centric
1.2.3 Drug-centric
1.2.4 Disease-centric
1.3 Market by Application
1.3.1 Global Drug Repurposing Serveice Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular Disorders
1.3.3 Central Nervous Disorders
1.3.4 Oncology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Repurposing Serveice Market Perspective (2020-2031)
2.2 Global Drug Repurposing Serveice Growth Trends by Region
2.2.1 Global Drug Repurposing Serveice Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Repurposing Serveice Historic Market Size by Region (2020-2025)
2.2.3 Drug Repurposing Serveice Forecasted Market Size by Region (2026-2031)
2.3 Drug Repurposing Serveice Market Dynamics
2.3.1 Drug Repurposing Serveice Industry Trends
2.3.2 Drug Repurposing Serveice Market Drivers
2.3.3 Drug Repurposing Serveice Market Challenges
2.3.4 Drug Repurposing Serveice Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Repurposing Serveice Players by Revenue
3.1.1 Global Top Drug Repurposing Serveice Players by Revenue (2020-2025)
3.1.2 Global Drug Repurposing Serveice Revenue Market Share by Players (2020-2025)
3.2 Global Drug Repurposing Serveice Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Repurposing Serveice Revenue
3.4 Global Drug Repurposing Serveice Market Concentration Ratio
3.4.1 Global Drug Repurposing Serveice Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Serveice Revenue in 2024
3.5 Global Key Players of Drug Repurposing Serveice Head office and Area Served
3.6 Global Key Players of Drug Repurposing Serveice, Product and Application
3.7 Global Key Players of Drug Repurposing Serveice, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repurposing Serveice Breakdown Data by Type
4.1 Global Drug Repurposing Serveice Historic Market Size by Type (2020-2025)
4.2 Global Drug Repurposing Serveice Forecasted Market Size by Type (2026-2031)
5 Drug Repurposing Serveice Breakdown Data by Application
5.1 Global Drug Repurposing Serveice Historic Market Size by Application (2020-2025)
5.2 Global Drug Repurposing Serveice Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Repurposing Serveice Market Size (2020-2031)
6.2 North America Drug Repurposing Serveice Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Repurposing Serveice Market Size by Country (2020-2025)
6.4 North America Drug Repurposing Serveice Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Repurposing Serveice Market Size (2020-2031)
7.2 Europe Drug Repurposing Serveice Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Repurposing Serveice Market Size by Country (2020-2025)
7.4 Europe Drug Repurposing Serveice Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Repurposing Serveice Market Size (2020-2031)
8.2 Asia-Pacific Drug Repurposing Serveice Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Repurposing Serveice Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Repurposing Serveice Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Repurposing Serveice Market Size (2020-2031)
9.2 Latin America Drug Repurposing Serveice Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Repurposing Serveice Market Size by Country (2020-2025)
9.4 Latin America Drug Repurposing Serveice Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Repurposing Serveice Market Size (2020-2031)
10.2 Middle East & Africa Drug Repurposing Serveice Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Repurposing Serveice Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Repurposing Serveice Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Anaxomics Biotech SL
11.1.1 Anaxomics Biotech SL Company Details
11.1.2 Anaxomics Biotech SL Business Overview
11.1.3 Anaxomics Biotech SL Drug Repurposing Serveice Introduction
11.1.4 Anaxomics Biotech SL Revenue in Drug Repurposing Serveice Business (2020-2025)
11.1.5 Anaxomics Biotech SL Recent Development
11.2 Biovista
11.2.1 Biovista Company Details
11.2.2 Biovista Business Overview
11.2.3 Biovista Drug Repurposing Serveice Introduction
11.2.4 Biovista Revenue in Drug Repurposing Serveice Business (2020-2025)
11.2.5 Biovista Recent Development
11.3 Chemotargets
11.3.1 Chemotargets Company Details
11.3.2 Chemotargets Business Overview
11.3.3 Chemotargets Drug Repurposing Serveice Introduction
11.3.4 Chemotargets Revenue in Drug Repurposing Serveice Business (2020-2025)
11.3.5 Chemotargets Recent Development
11.4 IQVIA
11.4.1 IQVIA Company Details
11.4.2 IQVIA Business Overview
11.4.3 IQVIA Drug Repurposing Serveice Introduction
11.4.4 IQVIA Revenue in Drug Repurposing Serveice Business (2020-2025)
11.4.5 IQVIA Recent Development
11.5 Eurofins DiscoverX
11.5.1 Eurofins DiscoverX Company Details
11.5.2 Eurofins DiscoverX Business Overview
11.5.3 Eurofins DiscoverX Drug Repurposing Serveice Introduction
11.5.4 Eurofins DiscoverX Revenue in Drug Repurposing Serveice Business (2020-2025)
11.5.5 Eurofins DiscoverX Recent Development
11.6 NUVISAN
11.6.1 NUVISAN Company Details
11.6.2 NUVISAN Business Overview
11.6.3 NUVISAN Drug Repurposing Serveice Introduction
11.6.4 NUVISAN Revenue in Drug Repurposing Serveice Business (2020-2025)
11.6.5 NUVISAN Recent Development
11.7 CD ComputaBio
11.7.1 CD ComputaBio Company Details
11.7.2 CD ComputaBio Business Overview
11.7.3 CD ComputaBio Drug Repurposing Serveice Introduction
11.7.4 CD ComputaBio Revenue in Drug Repurposing Serveice Business (2020-2025)
11.7.5 CD ComputaBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Drug Repurposing Serveice Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Target-centric
 Table 3. Key Players of Drug-centric
 Table 4. Key Players of Disease-centric
 Table 5. Global Drug Repurposing Serveice Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Drug Repurposing Serveice Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Drug Repurposing Serveice Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Drug Repurposing Serveice Market Share by Region (2020-2025)
 Table 9. Global Drug Repurposing Serveice Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Drug Repurposing Serveice Market Share by Region (2026-2031)
 Table 11. Drug Repurposing Serveice Market Trends
 Table 12. Drug Repurposing Serveice Market Drivers
 Table 13. Drug Repurposing Serveice Market Challenges
 Table 14. Drug Repurposing Serveice Market Restraints
 Table 15. Global Drug Repurposing Serveice Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Drug Repurposing Serveice Market Share by Players (2020-2025)
 Table 17. Global Top Drug Repurposing Serveice Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing Serveice as of 2024)
 Table 18. Ranking of Global Top Drug Repurposing Serveice Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Drug Repurposing Serveice Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Drug Repurposing Serveice, Headquarters and Area Served
 Table 21. Global Key Players of Drug Repurposing Serveice, Product and Application
 Table 22. Global Key Players of Drug Repurposing Serveice, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Drug Repurposing Serveice Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Drug Repurposing Serveice Revenue Market Share by Type (2020-2025)
 Table 26. Global Drug Repurposing Serveice Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Drug Repurposing Serveice Revenue Market Share by Type (2026-2031)
 Table 28. Global Drug Repurposing Serveice Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Drug Repurposing Serveice Revenue Market Share by Application (2020-2025)
 Table 30. Global Drug Repurposing Serveice Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Drug Repurposing Serveice Revenue Market Share by Application (2026-2031)
 Table 32. North America Drug Repurposing Serveice Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Drug Repurposing Serveice Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Drug Repurposing Serveice Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Drug Repurposing Serveice Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Drug Repurposing Serveice Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Drug Repurposing Serveice Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Drug Repurposing Serveice Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Drug Repurposing Serveice Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Drug Repurposing Serveice Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Drug Repurposing Serveice Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Drug Repurposing Serveice Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Drug Repurposing Serveice Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Drug Repurposing Serveice Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Drug Repurposing Serveice Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Drug Repurposing Serveice Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Anaxomics Biotech SL Company Details
 Table 48. Anaxomics Biotech SL Business Overview
 Table 49. Anaxomics Biotech SL Drug Repurposing Serveice Product
 Table 50. Anaxomics Biotech SL Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 51. Anaxomics Biotech SL Recent Development
 Table 52. Biovista Company Details
 Table 53. Biovista Business Overview
 Table 54. Biovista Drug Repurposing Serveice Product
 Table 55. Biovista Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 56. Biovista Recent Development
 Table 57. Chemotargets Company Details
 Table 58. Chemotargets Business Overview
 Table 59. Chemotargets Drug Repurposing Serveice Product
 Table 60. Chemotargets Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 61. Chemotargets Recent Development
 Table 62. IQVIA Company Details
 Table 63. IQVIA Business Overview
 Table 64. IQVIA Drug Repurposing Serveice Product
 Table 65. IQVIA Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 66. IQVIA Recent Development
 Table 67. Eurofins DiscoverX Company Details
 Table 68. Eurofins DiscoverX Business Overview
 Table 69. Eurofins DiscoverX Drug Repurposing Serveice Product
 Table 70. Eurofins DiscoverX Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 71. Eurofins DiscoverX Recent Development
 Table 72. NUVISAN Company Details
 Table 73. NUVISAN Business Overview
 Table 74. NUVISAN Drug Repurposing Serveice Product
 Table 75. NUVISAN Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 76. NUVISAN Recent Development
 Table 77. CD ComputaBio Company Details
 Table 78. CD ComputaBio Business Overview
 Table 79. CD ComputaBio Drug Repurposing Serveice Product
 Table 80. CD ComputaBio Revenue in Drug Repurposing Serveice Business (2020-2025) & (US$ Million)
 Table 81. CD ComputaBio Recent Development
 Table 82. Research Programs/Design for This Report
 Table 83. Key Data Information from Secondary Sources
 Table 84. Key Data Information from Primary Sources
 Table 85. Authors List of This Report


List of Figures
 Figure 1. Drug Repurposing Serveice Picture
 Figure 2. Global Drug Repurposing Serveice Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Drug Repurposing Serveice Market Share by Type: 2024 VS 2031
 Figure 4. Target-centric Features
 Figure 5. Drug-centric Features
 Figure 6. Disease-centric Features
 Figure 7. Global Drug Repurposing Serveice Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Drug Repurposing Serveice Market Share by Application: 2024 VS 2031
 Figure 9. Cardiovascular Disorders Case Studies
 Figure 10. Central Nervous Disorders Case Studies
 Figure 11. Oncology Case Studies
 Figure 12. Others Case Studies
 Figure 13. Drug Repurposing Serveice Report Years Considered
 Figure 14. Global Drug Repurposing Serveice Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Drug Repurposing Serveice Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Drug Repurposing Serveice Market Share by Region: 2024 VS 2031
 Figure 17. Global Drug Repurposing Serveice Market Share by Players in 2024
 Figure 18. Global Top Drug Repurposing Serveice Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing Serveice as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Drug Repurposing Serveice Revenue in 2024
 Figure 20. North America Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Drug Repurposing Serveice Market Share by Country (2020-2031)
 Figure 22. United States Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Drug Repurposing Serveice Market Share by Country (2020-2031)
 Figure 26. Germany Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Drug Repurposing Serveice Market Share by Region (2020-2031)
 Figure 34. China Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Drug Repurposing Serveice Market Share by Country (2020-2031)
 Figure 42. Mexico Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Drug Repurposing Serveice Market Share by Country (2020-2031)
 Figure 46. Turkey Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Drug Repurposing Serveice Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Anaxomics Biotech SL Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 50. Biovista Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 51. Chemotargets Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 52. IQVIA Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 53. Eurofins DiscoverX Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 54. NUVISAN Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 55. CD ComputaBio Revenue Growth Rate in Drug Repurposing Serveice Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart